These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

176 related articles for article (PubMed ID: 30557163)

  • 1. The Outcome of Patients With Localized Undifferentiated Pleomorphic Sarcoma of the Lower Extremity Treated at Stanford University.
    Kamat NV; Million L; Yao DH; Donaldson SS; Mohler DG; van de Rijn M; Avedian RS; Kapp DS; Ganjoo KN
    Am J Clin Oncol; 2019 Feb; 42(2):166-171. PubMed ID: 30557163
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Predicting the prognosis of undifferentiated pleomorphic soft tissue sarcoma: a 20-year experience of 266 cases.
    Vodanovich DA; Spelman T; May D; Slavin J; Choong PFM
    ANZ J Surg; 2019 Sep; 89(9):1045-1050. PubMed ID: 31364245
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Analysis of Clinical and Molecular Factors Impacting Oncologic Outcomes in Undifferentiated Pleomorphic Sarcoma.
    Roland CL; May CD; Watson KL; Al Sannaa GA; Dineen SP; Feig R; Landers S; Ingram DR; Wang WL; Guadagnolo BA; Feig B; Hunt KK; Cormier JN; Lazar AJ; Torres KE
    Ann Surg Oncol; 2016 Jul; 23(7):2220-8. PubMed ID: 26847678
    [TBL] [Abstract][Full Text] [Related]  

  • 4. MFH revisited: outcome after surgical treatment of undifferentiated pleomorphic or not otherwise specified (NOS) sarcomas of the extremities -- an analysis of 140 patients.
    Lehnhardt M; Daigeler A; Homann HH; Schwaiberger V; Goertz O; Kuhnen C; Steinau HU
    Langenbecks Arch Surg; 2009 Mar; 394(2):313-20. PubMed ID: 18584203
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Undifferentiated pleomorphic sarcoma: Factors predictive of adverse outcomes.
    Winchester D; Lehman J; Tello T; Chimato N; Hocker T; Kim S; Chang J; Markey J; Yom SS; Ryan W; Mully T; Hodge D; Otley C; Arron ST
    J Am Acad Dermatol; 2018 Nov; 79(5):853-859. PubMed ID: 29787841
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Why do patients with low-grade soft tissue sarcoma die?
    Canter RJ; Qin LX; Ferrone CR; Maki RG; Singer S; Brennan MF
    Ann Surg Oncol; 2008 Dec; 15(12):3550-60. PubMed ID: 18830667
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The Impact of Perioperative Chemotherapy Timing in Conjunction With Postoperative External-Beam Radiation Therapy on Extremity Soft-Tissue Sarcomas Outcome.
    Mahmoud O; Dosch A; Kwon D; Pitcher JD; Conway S; Benedetto P; Fernandez G; Trent J; Temple HT; Wolfson AH
    Am J Clin Oncol; 2016 Oct; 39(5):528-34. PubMed ID: 24879472
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Neoadjuvant chemoradiotherapy for patients with high-risk extremity and truncal sarcomas: a 10-year single institution retrospective study.
    Look Hong NJ; Hornicek FJ; Harmon DC; Choy E; Chen YL; Yoon SS; Nielsen GP; Szymonifka J; Yeap BY; DeLaney TF; Mullen JT
    Eur J Cancer; 2013 Mar; 49(4):875-83. PubMed ID: 23092789
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The pretreatment erythrocyte sedimentation rate predicts survival outcomes after surgery and adjuvant radiotherapy for extremity soft tissue sarcoma.
    Park G; Song SY; Ahn JH; Kim WL; Lee JS; Jeong SY; Park JW; Choi EK; Choi W; Jung IH
    Radiat Oncol; 2019 Jul; 14(1):116. PubMed ID: 31272506
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Primary malignant fibrous histiocytoma of long bones: long-term follow-up.
    Özkurt B; Başarır K; Yıldız YH; Kalem M; Sağlık Y
    Eklem Hastalik Cerrahisi; 2016 Aug; 27(2):94-9. PubMed ID: 27499321
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Natural history of undifferentiated pleomorphic sarcoma: Experience from the US Sarcoma Collaborative.
    Makris EA; Tran TB; Delitto DJ; Lee B; Ethun CG; Grignol V; Harrison Howard J; Bedi M; Clark Gamblin T; Tseng J; Roggin KK; Chouliaras K; Votanopoulos K; Cullinan D; Fields RC; Cardona K; Poultsides G; Kirane A
    J Surg Oncol; 2024 Jun; 129(7):1354-1363. PubMed ID: 38562002
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Significant benefits in survival by the use of surgery combined with radiotherapy for retroperitoneal soft tissue sarcoma.
    Hager S; Makowiec F; Henne K; Hopt UT; Wittel UA
    Radiat Oncol; 2017 Jan; 12(1):29. PubMed ID: 28126006
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Assessing the Role of Neoadjuvant Chemotherapy in Primary High-Risk Truncal/Extremity Soft Tissue Sarcomas: An Analysis of the Multi-institutional U.S. Sarcoma Collaborative.
    Zaidi MY; Ethun CG; Tran TB; Poultsides G; Grignol VP; Howard JH; Bedi M; Mogal H; Tseng J; Roggin KK; Chouliaras K; Votanopoulos K; Krasnick B; Fields RC; Oskouei S; Reimer N; Monson D; Maithel SK; Cardona K
    Ann Surg Oncol; 2019 Oct; 26(11):3542-3549. PubMed ID: 31342400
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Oncological outcome of patients with deeply located soft tissue sarcoma of the pelvis: a follow up study at minimum 5 years after diagnosis.
    Nakamura T; Abudu A; Murata H; Grimer RJ; Carter SR; Tillman RM; Jeys L
    Eur J Surg Oncol; 2013 Sep; 39(9):1030-5. PubMed ID: 23347778
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Radiotherapy leads to improved overall survival in patients undergoing resection for Undifferentiated pleomorphic sarcoma.
    Tepper SC; Lee L; Fice MP; Jones CM; Buac N; Vijayakumar G; Wang D; Colman MW; Gitelis S; Blank AT
    Surg Oncol; 2024 Oct; 56():102118. PubMed ID: 39121675
    [TBL] [Abstract][Full Text] [Related]  

  • 16. MFH and high-grade undifferentiated pleomorphic sarcoma-what's in a name?
    Delisca GO; Mesko NW; Alamanda VK; Archer KR; Song Y; Halpern JL; Schwartz HS; Holt GE
    J Surg Oncol; 2015 Feb; 111(2):173-7. PubMed ID: 25219789
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Radiation-Associated Undifferentiated Pleomorphic Sarcoma is Associated with Worse Clinical Outcomes than Sporadic Lesions.
    Dineen SP; Roland CL; Feig R; May C; Zhou S; Demicco E; Sannaa GA; Ingram D; Wang WL; Ravi V; Guadagnolo A; Lev D; Pollock RE; Hunt K; Cormier J; Lazar A; Feig B; Torres KE
    Ann Surg Oncol; 2015 Nov; 22(12):3913-20. PubMed ID: 25743327
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The clinical outcomes of undifferentiated pleomorphic sarcoma (UPS): A single-centre experience of two decades with the assessment of PD-L1 expressions.
    Lee K; Song JS; Kim JE; Kim W; Song SY; Lee MH; Chung HW; Cho KJ; Lee JS; Ahn JH
    Eur J Surg Oncol; 2020 Jul; 46(7):1287-1293. PubMed ID: 32127249
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Predictors and clinical significance of local recurrence in extremity soft tissue sarcoma.
    Alamanda VK; Crosby SN; Archer KR; Song Y; Schwartz HS; Holt GE
    Acta Oncol; 2013 May; 52(4):793-802. PubMed ID: 22877243
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Malignant fibrous histiocytoma: outcome and prognostic factors following conservation surgery and radiotherapy.
    Zagars GK; Mullen JR; Pollack A
    Int J Radiat Oncol Biol Phys; 1996 Mar; 34(5):983-94. PubMed ID: 8600111
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.